The Industrialization of Exceptions: When Compounding Crosses the Line from Patient Care to Patent Theft
In the rapidly evolving landscape of pharmaceutical innovation, a quiet but profound shift is underway—one that threatens to blur the lines between patient care and intellectual property rights. The recent surge in the industrialization of exceptions i…
